BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Amgen Nervous As FDA Paves Way For Novartis AG To Copy Drug Neupogen     7/28/2014
Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial     7/24/2014
FDA Approves Eagle Pharmaceuticals' Ryanodex® For The Treatment Of Malignant Hyperthermia     7/23/2014
Eli Lilly and Company Inks $45 Million Immunotherapy Development Deal With Immunocore Limited     7/16/2014
Prima Biomed Appoints New Chief Executive Officer     7/9/2014
Sun Pharmaceutical Industries Ltd Recalls 200 Vials Of Cancer Drug Gemcitabine: FDA     7/3/2014
Cancer Drug Olaparib Setback Tarnishes AstraZeneca PLC's R&D Claims     6/27/2014
Drug Giant Bayer HealthCare, Dimension Therapeutics Seal A Pact Worth $252 Million     6/23/2014
Sanofi (France) Throws Cancer Drug Back To Merrimack Pharmaceuticals Inc.     6/23/2014
French Biotech Cellectis Surges As Pfizer Inc. Signs Cancer Immunotherapy Pact Worth $265 Million     6/19/2014
Redwood City's OncoMed Pharmaceuticals, Inc. Voluntarily Halts Early-Stage Trials for Two Cancer Drugs     6/16/2014
Geron Corporation Jumps As FDA Lifts Partial Hold On Myelofibrosis IST     6/12/2014
Telormedix' Vesimune Successfully Completes Phase 2 For Carcinoma In Situ Of The Bladder     5/16/2014
Health Canada In A Battle Over Biolyse Pharma's Shutdown     5/15/2014
Seattle's Juno Therapeutics Pauses Trial After Patient Deaths     4/10/2014
 Featured Stories
Total Darkness During The Night Is A Key To Success Of Breast Cancer Therapy, Tulane University Study     7/28/2014
One Third Of Cancer Patients Are Killed By A Fat-Burning Process Termed Cachexia, Spanish National Cancer Research Center Study     7/18/2014
Cat Poop Parasite May Play A Role In Curing Cancer, Dartmouth Hitchcock Medical Center Study     7/18/2014
How Antioxidants Can Accelerate Cancers And Why They Don't Protect Against Them, Cold Spring Harbor Laboratory Scientists Reveal     7/14/2014
Sunshine Vitamin D Boosts Survival Chances In Bowel Cancer, University of Edinburgh Study     7/9/2014
Chinese Herbal Extract May Help Kill Off Pancreatic Cancer Cells, American Physiological Society Reveals     7/3/2014
No Link Found Between Fertility Drugs And Cancers, University of Illinois Study     7/1/2014
Low-Dose Aspirin Slashes Pancreatic Cancer Risk In Half, Yale University Study     6/30/2014
Too Much TV Linked To Early Death, University of Navarra Study     6/26/2014
Harmless Virus Kills Cancer And Tumor Cells, Pennsylvania State University Study     6/26/2014
Mayo Clinic Researchers Say Gene In Brain Linked To Kidney Cancer     6/25/2014
Eating Broccoli May Give Harmful Chemicals The Boot, Cancer Prevention Research Reveals     6/24/2014
Ovarian Cancer Treatment Discovered By St. Joseph's Hospital Researchers     6/23/2014
No Proof That Soy Food Protects Against Cancer, National Cancer Center Study     6/20/2014
Single Drug Could Soon Cure High Cholesterol, Breast Cancer, University of Missouri Study     6/19/2014
 More News
EMD Serono Initiates Phase 2 Study Of Anti-PD-L1 Antibody MSB0010718C In Metastatic Merkel Cell Carcinoma     7/29/2014
Statement From Tim Turnham, Executive Director, Melanoma Research Foundation, Regarding Surgeon General's Skin Cancer Call To Action     7/29/2014
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval Of IMBRUVICA® (Ibrutinib) For Treatment Of Two Blood Cancers     7/25/2014
Bavarian Nordic (BAVA.CO) Announces First Patient Treated In A Phase 1 Study Of MVA-BN® Brachyury In Advanced Cancer     7/24/2014
Advaxis, Inc. And MedImmune (AZN) Partner On Immuno-Oncology Combination Clinical Trial     7/22/2014
Access Pharmaceuticals (ACCP) Receives 510(K) FDA Marketing Clearance For ProctiGard™     7/22/2014
CASI Pharmaceuticals  (ENMD) To Start China Trial Of Cancer Drug     7/21/2014
"MetaMax" LLC Maxwell Biotech Venture Fund's Portfolio Company MetaMax Announces Enrollment Of First Patients In Phase 1/2a Clinical Trial Of Its Lead Anticancer Drug MM-D37K     7/21/2014
Nuvilex (NVLX) And Austrianova Announce Results Of Clinical Trial In Dogs With Mammary Tumors Treated With Cell-In-A-Box® Plus Cyclophosphamide     7/17/2014
GenSpera Presents G-202 HCC Clinical Trial Update At 5th Asia-Pacific Primary Liver Cancer Expert Meeting     7/15/2014
Progenics Pharmaceuticals, Inc. (PGNX) Holds Conference Call This Morning On FDA Appeal Response Regarding Relistor® sNDA For Patients With Chronic Non-Cancer Pain     7/14/2014
BioTime (BTX) Announces Issuance Of 14 Patents In The Fields Of Regenerative Medicine, And Cancer Diagnosis And Therapy     7/14/2014
Hemispherx Biopharma (HEB) And Bioclones, A Leading South African Biotechnology Company, Join Forces On Novel Therapeutic Cancer Vaccine     7/14/2014
SillaJen Lead Product Pexa-Vec Featured In "Nature Reviews Cancer" Article Summarizing The Potential Of Oncolytic Immunotherapy     7/10/2014
NeoStem, Inc. Presents Five-Year Survival Data For Autologous Melanoma Immunotherapy Targeting Cancer Stem Cells At American Society of Clinical Oncology Annual Meeting     7/9/2014